1255056001: Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Selective adhesion molecule inhibitor-containing product\Alpha-4 integrin receptor antagonist-containing product\Vedolizumab-containing product\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Selective adhesion molecule inhibitor-containing product\Alpha-4 integrin receptor antagonist-containing product\Vedolizumab-containing product\Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Vedolizumab-containing product\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Vedolizumab-containing product\Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Vedolizumab-containing product\...
• \Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial
• \Product manufactured as parenteral dose form\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial

Status: current, Defined. Date: 31-Oct 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5144261012	Vedolizumab 300 mg powder for solution for infusion and/or injection vial	en	Synonym	Active	Case insensitive	SNOMED CT core
5144262017	Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start